Evaluation of the metabolism of PEP06, an endostatin-RGDRGD 30-amino-acid polypeptide and a promising novel drug for targeting tumor cells.

Authors:
Niu L; Zhou H; Lian Y; Gao Y; Liu Y and 6 more

Journal:
J Pharm Anal

Publication Year: 2022

DOI:
10.1016/j.jpha.2022.03.002

PMCID:
PMC9615537

PMID:
36320606

Journal Information

Full Title: J Pharm Anal

Abbreviation: J Pharm Anal

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that there are no conflicts of interest."

Evidence found in paper:

"Liyun Niu: Conceptualization, Methodology, Software, Validation, Formal analysis, Investigation, Data curation, Writing - Original draft preparation, Reviewing and Editing, Visualization; Huiyu Zhou: Software, Investigation; Yueru Lian: Investigation; Ya Gao: Investigation; Yulu Liu: Investigation; Ruolan Gu: Resources, Supervision; Zhuona Wu: Resources; Xiaoxia Zhu: Resources, Supervision; Hui Gan: Resources; Zhiyun Meng: Conceptualization, Funding acquisition; Guifang Dou: Conceptualization, Funding acquisition."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025